{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:01:07Z","timestamp":1784836867020,"version":"3.55.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lung cancer remains the leading cause of cancer mortality worldwide. While incidence and mortality describe population burden, they do not fully capture disease severity at the level of the individual patient. This study quantified the contemporary global burden, temporal trends, and future trajectory of tracheal, bronchus, and lung (TBL) cancer, and applied a multidimensional severity framework integrating fatal and non-fatal outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A global ecological analysis was conducted across 185 countries and territories using harmonized data from GLOBOCAN 2022, the Global Burden of Disease (GBD) 2023 study, and the UN World Population Prospects 2024. Contemporary burden was assessed using incident cases, deaths, age-standardized incidence and mortality rates (ASIR\/ASMR), disability-adjusted life years (DALYs), mortality-to-incidence ratio (MIR), and DALYs per incident case. Temporal trends in ASIR and ASMR (2010\u20132023) were estimated using log-linear regression to derive average annual percent change (AAPC). Projections to 2050 were generated under two scenarios: (1) constant 2022 rates reflecting demographic change only, and (2) trend-based projections extrapolating country-specific AAPCs. Disease severity was evaluated using a two-dimensional framework combining MIR and DALYs-per-case, which captures average lifetime health loss per diagnosed individual independent of population size or age structure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2022, an estimated 2.48 million new TBL cancer cases and 1.82 million deaths occurred globally, corresponding to ASIR and ASMR of 23.6 and 16.8 per 100,000, respectively. Global DALYs reached 46.7 million, yielding 18.8 DALYs per case, with substantially higher burden in males and in higher-SDI regions. From 2010-2023, age-standardized rates increased in most low- and middle-income countries and declined predominantly in high-income settings. By 2050, demographic change alone is projected to drive large increases in burden in many low-resource countries, with further amplification under trend-based scenarios. DALYs-per-case showed a moderate positive correlation with MIR (Spearman\u2019s r_s\u2009=\u20090.46), revealing marked heterogeneity in severity profiles across countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Global lung cancer burden is projected to rise substantially in many regions despite declining rates in high-income settings. Integrating DALYs-per-case with MIR provides a complementary severity lens that highlights inequities not captured by incidence and mortality alone and supports more targeted prevention, treatment, and survivorship strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0354350","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:03:12Z","timestamp":1784833392000},"page":"e0354350","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global lung cancer burden, trends, and projections from 2010 to 2050: A population-level severity framework integrating DALYs-per-case and mortality-to-incidence ratio"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6213-7019","authenticated-orcid":true,"given":"Omar","family":"Freihat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Aamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Cselik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpad","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sipos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"3","key":"pone.0354350.ref001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"F Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"10299","key":"pone.0354350.ref002","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"AA Thai","year":"2021","journal-title":"The Lancet"},{"issue":"7","key":"pone.0354350.ref003","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1916623","article-title":"The effect of advances in lung-cancer treatment on population mortality.","volume":"383","author":"H Nadia","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"pone.0354350.ref004","year":"2021"},{"issue":"9","key":"pone.0354350.ref005","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S2213-2600(21)00164-8","article-title":"Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019","volume":"9","author":"GBD 2019 Respiratory Tract Cancers Collaborators","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"3","key":"pone.0354350.ref006","article-title":"Global trends of early, middle, and late-onset lung cancer from 1990 to 2021: Results from the global burden of disease study 2021","volume":"14","author":"Z Li","year":"2025","journal-title":"Cancer Med"},{"key":"pone.0354350.ref007","doi-asserted-by":"crossref","first-page":"1609230","DOI":"10.3389\/fonc.2025.1609230","article-title":"Global, regional, and national burden of lung cancer attributable to second-hand smoke from 1990 to 2021: A systematic analysis based on the Global Burden of Disease Study 2021","volume":"15","author":"Z Zhang","year":"2025","journal-title":"Front Oncol"},{"issue":"1","key":"pone.0354350.ref008","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13045-024-01640-8","article-title":"Global burden of cancer and associated risk factors in 204 countries and territories, 1980\u20132021: A systematic analysis for the GBD 2021","volume":"17","author":"Z Wu","year":"2024","journal-title":"J Hematol Oncol"},{"issue":"1","key":"pone.0354350.ref009","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s13023-024-03342-3","article-title":"A systematic review of studies that estimated the burden of chronic non-communicable rare diseases using disability-adjusted life years","volume":"19","author":"CC Oliveira","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"pone.0354350.ref010","doi-asserted-by":"crossref","first-page":"102693","DOI":"10.1016\/j.canep.2024.102693","article-title":"Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN","volume":"93","author":"J Zhou","year":"2024","journal-title":"Cancer Epidemiol"},{"issue":"21","key":"pone.0354350.ref011","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1097\/CM9.0000000000003268","article-title":"Global burden of lung cancer in 2022 and projected burden in 2050","volume":"137","author":"L Guo","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"pone.0354350.ref012","article-title":"Cancer care disparities: Overcoming barriers to cancer control in low- and middle-income countries","volume":"10","author":"OA Bamodu","year":"2024","journal-title":"JCO Glob Oncol"},{"key":"pone.0354350.ref013","doi-asserted-by":"crossref","unstructured":"Ji X, Chen J, Ye J, Xu S, Lin B, Hou K. Epidemiological analysis of global and regional lung cancer mortality: Based on 30-year data analysis of global burden disease database. In: Healthcare. MDPI; 2023. 2920.","DOI":"10.3390\/healthcare11222920"},{"issue":"9","key":"pone.0354350.ref014","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S2213-2600(21)00164-8","article-title":"Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","author":"GBD 2019 Respiratory Tract Cancers Collaborators","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"12","key":"pone.0354350.ref015","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-2667(21)00157-2","article-title":"Disparities in stage at diagnosis for five common cancers in China: A multicentre, hospital-based, observational study","volume":"6","author":"H Zeng","year":"2021","journal-title":"Lancet Public Health"},{"key":"pone.0354350.ref016","article-title":"Projections of lung cancer incidence by 2035 in 40 countries worldwide: Population-based study","volume":"9","author":"G Luo","year":"2023","journal-title":"JMIR Public Health Surveill"},{"key":"pone.0354350.ref017","unstructured":"Economic D of. World Population Prospects 2024: Summary of Results. Stylus Publishing, LLC; 2024."},{"key":"pone.0354350.ref018","doi-asserted-by":"crossref","first-page":"1054200","DOI":"10.3389\/fpubh.2023.1054200","article-title":"Epidemiological and demographic drivers of lung cancer mortality from 1990 to 2019: Results from the global burden of disease study 2019","volume":"11","author":"Y Fan","year":"2023","journal-title":"Front Public Health"},{"issue":"10440","key":"pone.0354350.ref019","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021. The","volume":"403","author":"AJ Ferrari","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"pone.0354350.ref020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12963-025-00425-6","article-title":"Estimated disability weights for the severity of health outcomes: A systematic review and meta-analysis","volume":"23","author":"X Liu","year":"2025","journal-title":"Popul Health Metr"},{"key":"pone.0354350.ref021","article-title":"Cancer survival in Africa, asia, the caribbean and central America","volume":"162","author":"R Sankaranarayanan","year":"2011","journal-title":"International Agency for Research on Cancer Lyon, France"},{"issue":"5","key":"pone.0354350.ref022","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/eurpub\/ckq120","article-title":"The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival","volume":"21","author":"F Asadzadeh Vostakolaei","year":"2011","journal-title":"Eur J Public Health"},{"key":"pone.0354350.ref023","volume-title":"The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020: summary","author":"CJL Murray","year":"1996"},{"issue":"9859","key":"pone.0354350.ref024","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: A systematic analysis for the Global Burden of Disease Study 2010. The","volume":"380","author":"CJL Murray","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"pone.0354350.ref025","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(15)00069-8","article-title":"Disability weights for the Global Burden of Disease 2013 study","volume":"3","author":"JA Salomon","year":"2015","journal-title":"Lancet Glob Health"},{"issue":"3","key":"pone.0354350.ref026","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00038-014-0553-y","article-title":"DALY calculation in practice: A stepwise approach","volume":"59","author":"B Devleesschauwer","year":"2014","journal-title":"Int J Public Health"},{"issue":"10125","key":"pone.0354350.ref027","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): Analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"C Allemani","year":"2018","journal-title":"Lancet"},{"issue":"10513","key":"pone.0354350.ref028","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","article-title":"Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990\u20132023: A systematic analysis for the Global Burden of Disease Study 2023. The","volume":"406","author":"M Naghavi","year":"2025","journal-title":"Lancet."},{"key":"pone.0354350.ref029","doi-asserted-by":"crossref","first-page":"101431","DOI":"10.1016\/j.lanepe.2025.101431","article-title":"The burden of diseases, injuries, and risk factors by voivodship in Poland, 1990\u20132023: A systematic analysis for the Global Burden of Disease Study 2023","volume":"58","author":"Collaborators GBD 2023 P","year":"2025","journal-title":"The Lancet Regional Health-Europe"},{"issue":"6","key":"pone.0354350.ref030","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"F Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"29","key":"pone.0354350.ref031","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/sim.3733","article-title":"Estimating average annual per cent change in trend analysis","volume":"28","author":"LX Clegg","year":"2009","journal-title":"Stat Med"},{"issue":"3","key":"pone.0354350.ref032","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"HJ Kim","year":"2000","journal-title":"Stat Med"},{"key":"pone.0354350.ref033","doi-asserted-by":"crossref","first-page":"1622954","DOI":"10.3389\/fpubh.2025.1622954","article-title":"Global burden and projections of breast cancer incidence and mortality to 2050: A comprehensive analysis of GLOBOCAN data","volume":"13","author":"O Freihat","year":"2025","journal-title":"Front Public Health"},{"issue":"12","key":"pone.0354350.ref034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0336036","article-title":"Global burden and future projections of non-communicable diseases (2000-2050): Progress toward SDG 3.4 and disparities across regions and risk factors","volume":"20","author":"O Freihat","year":"2025","journal-title":"PLoS One"},{"key":"pone.0354350.ref035","author":"M Dunn"},{"issue":"1","key":"pone.0354350.ref036","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrc1781","article-title":"Predicting the future burden of cancer","volume":"6","author":"F Bray","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"10159","key":"pone.0354350.ref037","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016-40 for 195 countries and territories","volume":"392","author":"KJ Foreman","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"pone.0354350.ref038","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12963-026-00469-2","article-title":"Reframing disease burden: Validation of DALY-per-case as a per-diagnosis severity metric","volume":"24","author":"O Freihat","year":"2026","journal-title":"Popul Health Metr"},{"issue":"12","key":"pone.0354350.ref039","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(21)00367-3","article-title":"Lifetime burden of disease due to incident tuberculosis: A global reappraisal including post-tuberculosis sequelae","volume":"9","author":"NA Menzies","year":"2021","journal-title":"Lancet Glob Health"},{"key":"pone.0354350.ref040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2288-12-125","article-title":"Estimating and validating disability-adjusted life years at the global level: A methodological framework for cancer","volume":"12","author":"I Soerjomataram","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"pone.0354350.ref041","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: A systematic analysis for the global burden of disease study 2019","volume":"8","author":"Global Burden of Disease 2019 Cancer Collaboration","year":"2022","journal-title":"JAMA Oncol"},{"issue":"1","key":"pone.0354350.ref042","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40164-025-00634-7","article-title":"Disparities in the incidence, mortality and disability-adjusted life years of 33 early-onset cancer groups globally, 2012-2021: A systematic analysis","volume":"14","author":"W Yan","year":"2025","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"pone.0354350.ref043","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00038-014-0552-z","article-title":"Calculating disability-adjusted life years to quantify burden of disease","volume":"59","author":"B Devleesschauwer","year":"2014","journal-title":"Int J Public Health"},{"issue":"4","key":"pone.0354350.ref044","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10147-021-02108-2","article-title":"Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050","volume":"27","author":"R Sharma","year":"2022","journal-title":"Int J Clin Oncol"},{"key":"pone.0354350.ref045","year":"2021"},{"issue":"13","key":"pone.0354350.ref046","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/CM9.0000000000002529","article-title":"Global burden and trends of lung cancer incidence and mortality","volume":"136","author":"C Li","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"pone.0354350.ref047","first-page":"1","article-title":"The mortality-to-incidence ratio is not a valid proxy for cancer survival","volume":"5","author":"L Ellis","year":"2019","journal-title":"J Glob Oncol"},{"issue":"10125","key":"pone.0354350.ref048","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The","volume":"391","author":"C Allemani","year":"2018","journal-title":"Lancet"},{"issue":"10","key":"pone.0354350.ref049","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","article-title":"Planning for tomorrow: Global cancer incidence and the role of prevention 2020-2070","volume":"18","author":"I Soerjomataram","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"pone.0354350.ref050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: Global statistics for 2020 and 2040","volume":"66","author":"M Arnold","year":"2022","journal-title":"The Breast"},{"issue":"10159","key":"pone.0354350.ref051","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories","volume":"392","author":"KJ Foreman","year":"2018","journal-title":"The Lancet"},{"issue":"12","key":"pone.0354350.ref052","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study","volume":"5","author":"C Fitzmaurice","year":"2019","journal-title":"JAMA Oncol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:03:21Z","timestamp":1784833401000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354350"}},"subtitle":[],"editor":[{"given":"Ming-Ching","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":52,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0354350","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}